covid
Buscar en
Anales de Pediatría Continuada
Toda la web
Inicio Anales de Pediatría Continuada Procalcitonina en la valoración del niño con fiebre sin foco
Información de la revista
Vol. 2. Núm. 2.
Páginas 97-100 (enero 2004)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 2. Núm. 2.
Páginas 97-100 (enero 2004)
Acceso a texto completo
Procalcitonina en la valoración del niño con fiebre sin foco
Visitas
8967
Anna Fernández, Carles Luaces, Jordi Pou
Servicio de Pediatría. Unidad Integrada Hospital Sant Joan de Déu-Clínic. Universitat de Barcelona. Barcelona. España.
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
bibliografía
[1.]
J. Korta, J.R. Lasarte, M. Lertxundi, J. Alústiza.
Manejo del lactante febril sin foco.
Bol S Vasco Nav Pediatr, 34 (2000), pp. 124-131
[2.]
febril El niño.
Resultados de un estudio multicéntrico. Grupo de Trabajo sobre el Niño Febril. Sociedad Espanola de Urgencias de Pediatría.
An Esp Pediatr, 55 (2001), pp. 5-10
[3.]
G.M. Lee, G.R. Fleisher, M.B. Harper.
Management of febrile children in the age of the conjugate pneumococcal vaccine: a cost-effectiveness analysis.
Pediatrics, 108 (2001), pp. 833-844
[4.]
M. Lorrot, F. Moulin, J. Coste, S. Ravilly, S. Guérin, P. Lebon, et al.
Procalcitonine aux urgencies pédiatriques: comparaison avec la protéine C reactive, L'interleukine-6 et l'interféron-alpha pour la différenciation des infections bactériennes et virales.
La Presse Medicale, 29 (2000), pp. 128-134
[5.]
A. Fernández, C. Luaces, J.J. Garcia.
Pou J and the working group of the Spanish Society of Pediatric Emergencies (SEUP) for the study of procalcitonin in emergency departments Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants. Results of a multicentre study and utility of a rapid qualitative test for this marker.
Pediatr Infect Dis J, 22 (2003), pp. 895-903
[6.]
B. AL Nawas, P.M. Shah.
Procalcitonin, a new diagnostic and pronostic marker for severe infections.
Clin Microbiol Infect, 4 (1998), pp. 237-241
[7.]
D. Gendrel, J. Raymond, J. Coste, F. Moulin, M. Lorrot, S. Guérin, et al.
Comparison of procalcitonin with C-reactive protein, interleukin-6 and interferon-alpha for differentiation of bacterial vs viral infections.
Pediatr Infect Dis J, 18 (1999), pp. 875-881
[8.]
S. Petijean, A. Mackensen, R. Engelhardt, C. Bohuon, M. Assicot.
Induction de la procalcitonine circulante aprés administration intraveineuse d'endotoxine chez l'homme.
Act Parm Biol Clin, 6 (1994), pp. 265-268
[9.]
A. Fernández, C. Luaces, C. Valls, J. Ortega, J.J. García, A. Mira, et al.
Procalcitónina para el diagnóstico precoz de infección bacteriana invasiva en el lactante febril.
An Esp Pediatr, 55 (2001), pp. 321-328
[10.]
J.V. Tovar, V. Giner, F. Navarro, E. Pascual.
Uso de la proteína C reactiva en la evaluación de la respuesta terapéutica en artritis séptica.
Med Clin (Barc), 88 (1987), pp. 432
[11.]
X. García-Moll, J. Guindo, J.C. Kaski.
Proteina C reactiva como factor de riesgo coronario.
Med Clin (Barc), 117 (2001), pp. 303-308
[12.]
D.L. Jaye, K.B. Waites.
Clinical applications of C-reactive protein in pediatrics.
Pediatr Infect Dis J, 16 (1997), pp. 735-747
[13.]
C. Ochoa, L. Inglada, J. Erois, G. Solis, A. Vallano, L. Guerra.
Appropriateness of antibiotic prescriptions in community.acquired acute pediatric respiratory infections in Spanish emergency rooms.
Pediatr Infect Dis J, 20 (2001), pp. 751-758
[14.]
M. Assicot, D. Gendrel, H. Carsin, J. Raymond, J. Guilbaud, C. Bohuhon.
High serum procalcitonin concentrations in patients with sepsis and infection.
Lancet, 341 (1993), pp. 515-518
[15.]
M. Meisner.
Laboratory issues: the laboratory determination of PCT.
Procalcitonin. A new, innovative infection parameter. Biochemical and clinical aspects, pp. 162-181
[16.]
P. Dandona, D. Nix, M.F. Wilson, A. Aljada, J. Love, M. Assicot, et al.
Procalcitonin increase after endotoxin injection in normal subjects.
J Clin Endocrinol Metab, 93 (1994), pp. 54-58
[17.]
D. Gendrel, C. Bohuon.
Procalcitonin as a marker of bacterial infection.
Pediatr Infect Dis J, 19 (2000), pp. 679-687
[18.]
Y. Gerad, D. Hober, S. Petijean, M. Assicot, C. Bohuon, Y. Mouton, et al.
High serum procalcitonin level in a 4-year old liver transplant recipient with disseminated candidiasis.
Infection, 23 (1995), pp. 310-311
[19.]
C. Chiesa, L. Pacifico, G. Mancuso, A. Panero.
Procalcitonin in Pediatrics: Overview and Challenge.
Infection, 4 (1998), pp. 236-241
[20.]
J. Casado Flores, A. Blanco Quirós.
Procalcitonina: un nuevo marcador de infección bacteriana.
An Esp Pediatr, 54 (2001), pp. 69-73
[21.]
O. Name, A. Fernández, C. Luaces.
Procalcitonina: una nueva herramienta diagnóstica en la infección bacteriana.
Med Clin (Barc), 119 (2002), pp. 707-714
[22.]
D. Gendrel, J. Raymond, M. Assicot, F. Moulin, J.L. Iniguez, P. Lebon, et al.
Measurement of procalcitonin levels in children with bacterial or viral meningitis.
Clin Infect Dis, 24 (1997), pp. 1240-1242
[23.]
M. Hatherill, S.M. Tibby, K. Sykes, C. Turner, I.A. Murdoch.
Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leukocyte count.
Arch Dis Child, 81 (1999), pp. 417-421
[24.]
A.G. Lacour, A. Gervaix, S.A. Zamora, L. Vadas, P.R. Lombard, J.M. Dayer, et al.
Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identifiers of serious bacterial infections in children with fever without localising signs.
Eur J Pediatr, 160 (2001), pp. 95-100
[25.]
E.D. Carrol, P. Newland, F.A. Riordan, A.P. Thomson, N. Curtis, C.A. Hart.
Procalcitonin as a diagnostic marker of meningococcal disease in children presenting with fever and a rash.
Arch Dis Child, 86 (2002), pp. 282-285
[26.]
D.C. Van der Kaay, E.D. De Kleijn, Y.B. De Rijke, W.C. Hop, R. De Groot, J.A. Hazelzet.
Procalcitonin as a prognostic marker in meningococcal disease.
Intensive Care Med, 28 (2002), pp. 1606-1612
[27.]
J. Casado, A. Blanco, J. Asensio, E. Arranz, J.A. Garrote, M. Nieto.
Serum procalcitonin in children with suspected sepsis: a comparison with C-reactive protein and neutrophil count.
Pediatr Crit Care Med, 4 (2003), pp. 264-266
[28.]
A. Galetto-Lacour, S.A. Zamora, A. Gervaix.
Bedside procalcitonin and C-reactive Protein tests in children with fever without localizing signs of infection seen in a referal center.
Pediatrics, 112 (2003), pp. 1054-1060
[29.]
G. Fleischhack, D. Cipic, J. Juettner, C. Hasan, U. Bode.
Procalcitonin. A sensitive inflammation marker of febrile episodes in neutropenic children with cancer.
Intens Care Med, 2 (2000), pp. 203-211
[30.]
C. Barnes, V. Ignjatovic, F. Newall, J. Carlin, F. Ng, S. Hamilton, et al.
Change in serum procalcitonin predicts the clinic outcome of children admitted with febrile neutropenia.
Br J Haematol, 118 (2002), pp. 1197-1198
[31.]
M. Sauer, K. Tiede, D. Fuchs, B. Gruhn, D. Berger, F. Zintl.
Procalcitonin, C-reactive protein, and endotoxin after bone marrow transplantation: identification of children at hig risk morbidity and mortality from sepsis.
Bone Marrow Transplant, 31 (2003), pp. 1137-1142
Copyright © 2004. Elsevier España, S.L.. Todos los derechos reservados
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos